How to measure dyspnea in acute heart failure?

Therapeutische Umschau

Volumn 66, Issue 9, 2009, Pages 639-642

  Socrates, Thenral ^a   Mebazaa, Alexandre ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b APHP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; CLINICAL PRACTICE; DISEASE COURSE; DYSPNEA; HUMAN; LUNG FUNCTION TEST; PATIENT POSITIONING; RATING SCALE; RECUMBENCY; REVIEW; SITTING; SYMPTOM; VISUAL ANALOG SCALE;

DYSPNEA; HEART FAILURE; HUMANS; PAIN; PAIN MEASUREMENT; RESPIRATORY FUNCTION TESTS;

EID: 69749106379     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.66.9.639     Document Type: Review

References (7)

1. Pang PS, Tavares M, Collins SP, Cleland JG, Hollander J, Nieminen M, Miller C, Courtney DM, Kirk JD, Masip J, Parkhomenko A, Macarie C, Peacock WF, Spinar J, Nowak R, Raev D, Storrow AB, Spisak V, Hamdy A, Mebazaa A, Gheorghiade M; URGENT Investigators Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study Am J Ther. 2008; 15: 299-303
2. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. Jama 2007; 298: 2009-2019. (Pubitemid 350074798)
3. Gheorghiade M, Konstam MA, Burnett JC, Jr., Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. Jama 2007; 297: 1332-1343. (Pubitemid 46513234)
4. VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. Jama 2002; 287 1531-1540. (Pubitemid 34269998)
5. Teerlink JR. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 2003; 145 (2 Suppl): S26-33.
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur J Heart Fail. 2008 Oct; 10: 933-989
7. Mebazaa A, Gheorghiade M, Piña IL, Harjola VP, Hollenberg SM, Follath F, Rhodes A, Plaisance P, Roland E, Nieminen M, Komajda M, Parkhomenko A, Masip J, Zannad F, Filippatos G. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes.Crit Care Med. 2008 Jan; 36 (1 Suppl): S129-39.